Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.
Saved in:
| Title: | Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. |
|---|---|
| Authors: | Ermann D; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT., Vardell V; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT., Zacholski E; Virginia Commonwealth University Health Hematology, Richmond, VA., Fegley A; Virginia Commonwealth University Health Hematology, Richmond, VA., Modi D; Karmanos Cancer Institute, Hematology, Detroit, MI., Fedak K; Karmanos Cancer Institute, Hematology, Detroit, MI., Sundaram S; Tisch Cancer Institute at Mount Sinai, Hematology, NYC, NY., Rajeeve S; Tisch Cancer Institute at Mount Sinai, Hematology, NYC, NY., Goyal G; University of Alabama Medicine, Hematology, Birmingham, AL., Hatic H; University of Alabama Medicine, Hematology, Birmingham, AL., Torka P; Memorial Sloan Kettering Cancer Center, Hematology Division, New York, NY., Ba Aqeel S; Roswell Park Comprehensive Cancer Center, Hematology, Bufallo, NY., Borogovac A; University of Oklahoma Health Sciences Center, Hematology, OKC, OK., MacDougall K; University of Oklahoma Health Sciences Center, Hematology, OKC, OK., Kothari S; Yale Comprehensive Cancer Center, Hematology, New Haven, CT., Kress A; Yale Comprehensive Cancer Center, Hematology, New Haven, CT., Travers E; University of Kentucky HealthCare, Hematology, Lexington, KY., Chilakamarri N; Pomona Valley Medical Center, Hematology, Pomona, CA., Brem E; UC Irvine, Hematology, CA., Ayyappan S; University of Iowa Holden Comprehensive Cancer Center, Hematology, Iowa City, IA., Sigmund A; The Ohio State Comprehensive Cancer Center, Hematology, Columbus, OH., Bond D; The Ohio State Comprehensive Cancer Center, Hematology, Columbus, OH., Fitzgerald L; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT., Wagner C; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT., Hu B; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT., Stephens DM; University of North Carolina Comprehensive Cancer Center, Hematology, Durham, NC., Shah H; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT. Electronic address: harsh.shah@hci.utah.edu. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 May; Vol. 26 (5), pp. e636-e642.e6. Date of Electronic Publication: 2026 Feb 02. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41763973 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ermann+D%22">Ermann D</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Vardell+V%22">Vardell V</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Zacholski+E%22">Zacholski E</searchLink>; Virginia Commonwealth University Health Hematology, Richmond, VA.<br /><searchLink fieldCode="AU" term="%22Fegley+A%22">Fegley A</searchLink>; Virginia Commonwealth University Health Hematology, Richmond, VA.<br /><searchLink fieldCode="AU" term="%22Modi+D%22">Modi D</searchLink>; Karmanos Cancer Institute, Hematology, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Fedak+K%22">Fedak K</searchLink>; Karmanos Cancer Institute, Hematology, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Sundaram+S%22">Sundaram S</searchLink>; Tisch Cancer Institute at Mount Sinai, Hematology, NYC, NY.<br /><searchLink fieldCode="AU" term="%22Rajeeve+S%22">Rajeeve S</searchLink>; Tisch Cancer Institute at Mount Sinai, Hematology, NYC, NY.<br /><searchLink fieldCode="AU" term="%22Goyal+G%22">Goyal G</searchLink>; University of Alabama Medicine, Hematology, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Hatic+H%22">Hatic H</searchLink>; University of Alabama Medicine, Hematology, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Torka+P%22">Torka P</searchLink>; Memorial Sloan Kettering Cancer Center, Hematology Division, New York, NY.<br /><searchLink fieldCode="AU" term="%22Ba+Aqeel+S%22">Ba Aqeel S</searchLink>; Roswell Park Comprehensive Cancer Center, Hematology, Bufallo, NY.<br /><searchLink fieldCode="AU" term="%22Borogovac+A%22">Borogovac A</searchLink>; University of Oklahoma Health Sciences Center, Hematology, OKC, OK.<br /><searchLink fieldCode="AU" term="%22MacDougall+K%22">MacDougall K</searchLink>; University of Oklahoma Health Sciences Center, Hematology, OKC, OK.<br /><searchLink fieldCode="AU" term="%22Kothari+S%22">Kothari S</searchLink>; Yale Comprehensive Cancer Center, Hematology, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Kress+A%22">Kress A</searchLink>; Yale Comprehensive Cancer Center, Hematology, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Travers+E%22">Travers E</searchLink>; University of Kentucky HealthCare, Hematology, Lexington, KY.<br /><searchLink fieldCode="AU" term="%22Chilakamarri+N%22">Chilakamarri N</searchLink>; Pomona Valley Medical Center, Hematology, Pomona, CA.<br /><searchLink fieldCode="AU" term="%22Brem+E%22">Brem E</searchLink>; UC Irvine, Hematology, CA.<br /><searchLink fieldCode="AU" term="%22Ayyappan+S%22">Ayyappan S</searchLink>; University of Iowa Holden Comprehensive Cancer Center, Hematology, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Sigmund+A%22">Sigmund A</searchLink>; The Ohio State Comprehensive Cancer Center, Hematology, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Bond+D%22">Bond D</searchLink>; The Ohio State Comprehensive Cancer Center, Hematology, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+L%22">Fitzgerald L</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Wagner+C%22">Wagner C</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Hu+B%22">Hu B</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; University of North Carolina Comprehensive Cancer Center, Hematology, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Shah+H%22">Shah H</searchLink>; University of Utah Huntsman Cancer Institute, Hematology, Salt Lake City, UT. Electronic address: harsh.shah@hci.utah.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2026 May; Vol. 26 (5), pp. e636-e642.e6. <i>Date of Electronic Publication: </i>2026 Feb 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41763973 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2026.01.018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e636 Titles: – TitleFull: Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ermann D – PersonEntity: Name: NameFull: Vardell V – PersonEntity: Name: NameFull: Zacholski E – PersonEntity: Name: NameFull: Fegley A – PersonEntity: Name: NameFull: Modi D – PersonEntity: Name: NameFull: Fedak K – PersonEntity: Name: NameFull: Sundaram S – PersonEntity: Name: NameFull: Rajeeve S – PersonEntity: Name: NameFull: Goyal G – PersonEntity: Name: NameFull: Hatic H – PersonEntity: Name: NameFull: Torka P – PersonEntity: Name: NameFull: Ba Aqeel S – PersonEntity: Name: NameFull: Borogovac A – PersonEntity: Name: NameFull: MacDougall K – PersonEntity: Name: NameFull: Kothari S – PersonEntity: Name: NameFull: Kress A – PersonEntity: Name: NameFull: Travers E – PersonEntity: Name: NameFull: Chilakamarri N – PersonEntity: Name: NameFull: Brem E – PersonEntity: Name: NameFull: Ayyappan S – PersonEntity: Name: NameFull: Sigmund A – PersonEntity: Name: NameFull: Bond D – PersonEntity: Name: NameFull: Fitzgerald L – PersonEntity: Name: NameFull: Wagner C – PersonEntity: Name: NameFull: Hu B – PersonEntity: Name: NameFull: Stephens DM – PersonEntity: Name: NameFull: Shah H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 26 – Type: issue Value: 5 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |